ArticleAmerican journal of preventive cardiology2025
Global trends in cardiovascular mortality attributable to high body mass index: 1990-2021 analysis with future projections.
Article in American journal of preventive cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Review
- Interrelationships Between Key Cardiovascular Risk Factors, Chronic Kidney Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease.Current cardiology reports · 2026Review
- Lowering barriers Not the bar: Redefining the role of American Journal of Preventive Cardiology in the next era.American journal of preventive cardiology · 2026Article
- Next-Generation Antioxidants in Cardiovascular Disease: Mechanistic Insights and Emerging Therapeutic Strategies.Antioxidants (Basel, Switzerland) · 2026Review
- Sphingolipid Metabolism: A Pathological Hub Linking Lipid Dysregulation and Chronic Inflammation in Atherosclerotic Cardiovascular Disease.Journal of inflammation research · 2026Review
- Trends and disparities in obesity and atherosclerotic cardiovascular disease mortality in a 25-year retrospective analysis.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Cardiovascular disease (CVD) remains a major global cause of death, with high body mass index (BMI) as a key modifiable risk factor. This study examines global and regional patterns of CVD mortality attributable to high BMI from 1990 to 2021, with projections to 2032. Methods: Using Global Burden of Disease 2021 data from 204 countries, we analyzed age-standardized mortality rates (ASMRs) and population-attributable fractions by sex, age, socio-demographic index (SDI), and region. Future trends were estimated using a Bayesian age-period-cohort model, with uncertainity intervals from 1000 posterior simulations. Results: High BMI-related deaths due to CVD rose from 0.9 million in 1990 to 1.9 million in 2021, with ASMR declining from 24.43 to 22.77 per 100,000 (-6.83 %). High-middle SDI regions had the highest ASMR, while low-middle SDI regions saw the largest increase. Mortality rose for hypertensive heart disease and atrial fibrillation and flutter, but declined for ischemic heart disease and stroke. Older adults accounted for most deaths, though ASMR increased among those aged 15-49. By 2032, deaths are projected to reach 2.5 million (+33 %), with ASMR dropping to 22.06. Conclusion: Despite modest ASMR declines, high-BMI-related CVD deaths are rising, especially in low-SDI regions, underscoring the need for targeted prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.